Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Remicade Patent Fight: Janssen Loses Big, But Pfizer Not Out Of Woods

Jan 24 2018

• By Brenda Sandburg

court house

Related Content

Can Janssen Revive Its Key Remicade Patent? Federal Circuit Hears Pitch

Oct 04 2017

Pfizer v. J&J Sets Stage For Biosimilar Showdown Over Exclusive Contracts

Sep 21 2017

Samsung's Biosimilar Manufacturing Documents Lead Janssen To Drop Infringement Suit

Nov 14 2017

Biosimilar Legal Landscape: Lessons From 2017

Jan 03 2018

Related Companies

Johnson & Johnson

Celltrion, Inc.

Pfizer Inc.

Lupin Limited

Additional Topics

United States Biosimilars Intellectual Property Legal Issues Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window